Your session is about to expire
← Back to Search
Reading Intervention for Dyslexia
N/A
Recruiting
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Must not have
Have Epilepsy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 weeks after baseline
Awards & highlights
No Placebo-Only Group
Summary
This trial will study whether a reading intervention can help improve brain function and reading ability in students with dyslexia.
Who is the study for?
This trial is for young students who have been diagnosed with dyslexia by school psychologists or psychiatrists. It's not open to those who also have ADHD, Autism, or Epilepsy.
What is being tested?
The study is testing a reading intervention called 'Set For Variability' against current best practices to see if there are positive changes in brain activity and reading skills in students with dyslexia.
What are the potential side effects?
Since this trial involves educational and behavioral interventions rather than medications, traditional side effects are not expected. However, participants may experience fatigue or frustration during the learning process.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have epilepsy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 weeks after baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 weeks after baseline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Physiological parameter using EEG
Secondary study objectives
Standardized reading measures
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Set for VariabilityExperimental Treatment1 Intervention
Students in the experimental group will receive an average of 10-12 hrs. of small group intervention. All lessons will include (i) a focus on blending and segmenting phonemes within a synthetic phonics model, (ii) teaching common, vocabulary words (iii)shared book reading, and (iv) Set-for-variability component (SfV). This component will focus on teaching students how to find the sound variation of a grapheme-phoneme rule. For example when to use the sound /k/in /ch/ to read words such as "stomach"
Group II: Current best practicesActive Control1 Intervention
The control group will receive current-best practices (CBP). The participants will receive a similar approach as in the intervention group without Set-for-Variability. The participants will receive (i) a focus on blending and segmenting phonemes within a synthetic phonics model, (ii) vocabulary, (iii) shared book reading, and (iv) the absence of teaching Set-for-Variability. Instead of Set-for-variability, the participants will receive sight word reading of frequent words. They will learn the most frequent pronunciation of vowels: ee, ea, oo, ou, oa, ai, ay
Find a Location
Who is running the clinical trial?
McGill UniversityLead Sponsor
412 Previous Clinical Trials
1,018,498 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have epilepsy.You have been diagnosed with both ADHD and autism.
Research Study Groups:
This trial has the following groups:- Group 1: Current best practices
- Group 2: Set for Variability
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.